Martin Ebinger

Promoter methylation pattern of caspase-8, P16INK4A, MGMT, TIMP-3, and E-cadherin in medulloblastoma.

P-glycoprotein is a factor in the uptake of dextromethorphan, but not of melperone, into the mouse brain: evidence for an overlap in substrate specificity between P-gp and CYP2D6.

Standard mono- and dinucleotide repeats do not appear to be sensitive markers of microsatellite instability in the Ewing family of tumors.

No aberrant methylation of neurofibromatosis 1 gene (NF1) promoter in pilocytic astrocytoma in childhood.

The anti-Parkinson drug budipine is exported actively out of the brain by P-glycoprotein in mice.

Expression of GAS7 in childhood CNS tumors.

Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls.

ABC drug transporter at the blood-brain barrier: effects on drug metabolism and drug response.

Olanzapine-induced oculogyric crisis.

Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients.

P-glycoprotein has negligible effects on estradiol and testosterone in mice.

Successful treatment of chronic fatigue syndrome with duloxetine and trijodthyronine--a case study.

Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.

Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemia.

Expediting MRI-based proof-of-concept stroke trials using an earlier imaging end point.

Clinical-diffusion mismatch and benefit from thrombolysis 3 to 6 hours after acute stroke.

Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET).

Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation.

Reliable perfusion maps in stroke MRI using arterial input functions derived from distal middle cerebral artery branches.

Prospective study on the mismatch concept in acute stroke patients within the first 24 h after symptom onset - 1000Plus study.

Fluid-attenuated inversion recovery evolution within 12 hours from stroke onset: a reliable tissue clock?

The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET).

Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis.

High frequency of immature cells at diagnosis predicts high minimal residual disease level in childhood acute lymphoblastic leukemia.

Clinical and radiological courses do not differ between fluid-attenuated inversion recovery-positive and negative patients with stroke after thrombolysis.

Hyperintense acute reperfusion marker on FLAIR is not associated with early haemorrhagic transformation in the elderly.

The role of fasting versus non-fasting triglycerides in ischemic stroke: a systematic review.

Triglycerides and stroke risk prediction: lessons from a prospective cohort study in german primary care patients.

High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia.

Long-term remission after first-line single-agent treatment with arsenic trioxide of relapsed acute promyelocytic leukemia in an 8-year-old boy.

Natural killer cell activity influences outcome after T cell depleted stem cell transplantation from matched unrelated and haploidentical donors.

DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study.

Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformation.

Fluid-attenuated inversion recovery images and stroke outcome after thrombolysis.

Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery.

Judgment of FLAIR signal change in DWI-FLAIR mismatch determination is a challenge to clinicians.

Endothelial dysfunction of the peripheral vascular bed in the acute phase after ischemic stroke.

Development and validation of a dispatcher identification algorithm for stroke emergencies.

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.

PHANTOM-S: the prehospital acute neurological therapy and optimization of medical care in stroke patients - study.

Dissecting the genomic complexity underlying medulloblastoma.

Hyperintense vessels on acute stroke fluid-attenuated inversion recovery imaging: associations with clinical and other MRI findings.

White matter lesion severity in mild acute ischemic stroke patients and functional outcome after 1 year.

Statins and cerebral perfusion in patients with leukoaraiosis--a translational proof-of-principal MRI study.

Quantitative measurements of relative fluid-attenuated inversion recovery (FLAIR) signal intensities in acute stroke for the prediction of time from symptom onset.

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

Prehospital thrombolysis in acute stroke: results of the PHANTOM-S pilot study.

Smoking-thrombolysis paradox: recanalization and reperfusion rates after intravenous tissue plasminogen activator in smokers with ischemic stroke.

Complete early reversal of diffusion-weighted imaging hyperintensities after ischemic stroke is mainly limited to small embolic lesions.

A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).

Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.

Response to letter regarding article, “smoking-thrombolysis paradox: recanalization and reperfusion rates after intravenous tissue plasminogen activator in smokers with ischemic stroke”.

Core topics in neuroanesthesia and neurointensive care.

Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.

Fasting versus post-challenge triglycerides and pre-existing cavitating lacunes: a berlin "cream & sugar" substudy.

Sequential decisions on FAS sequencing guided by biomarkersin patients with lymphoproliferation and autoimmune cytopenia.

Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas.